Mario Gabelli's CDTX Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 12,500 shares of Cidara Therapeutics, Inc. (CDTX) worth $2.76 M, representing 0.03% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Mario Gabelli has initiated a new position in CDTX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Cidara Therapeutics (CDTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cidara Therapeutics (CDTX) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +12,500 | New Buy | 12,500 | $220.89 |
Mario Gabelli's Cidara Therapeutics Investment FAQs
Mario Gabelli first purchased Cidara Therapeutics, Inc. (CDTX) in Q4 2025, acquiring 12,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Cidara Therapeutics, Inc. (CDTX) for 1 quarters since Q4 2025.
Mario Gabelli's largest addition to Cidara Therapeutics, Inc. (CDTX) was in Q4 2025, adding 12,500 shares worth $2.76 M.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 12,500 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $2.76 M.
As of the Q4 2025 filing, Cidara Therapeutics, Inc. (CDTX) represents approximately 0.03% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Cidara Therapeutics, Inc. (CDTX) was 12,500 shares, as reported at the end of Q4 2025.